North America Eubiotics Market 2021-2028

This report determines that the eubiotics market in North America is expected to showcase growth at a CAGR of 7.15% during the years 2021-2028. The United States and Canada form the market in the considered region.

The consumption rate of beef, pork, poultry products has surpassed other meat products across the US over the past years. Moreover, the rise in animal diseases poses a major challenge to the animal agriculture sector. As a result, the increase in animal disease outbreaks has increased awareness relating to animal health maintenance to ensure efficient food supply, supporting economic development. Besides, the animal health sector is vital in the country’s food supply chain, having a huge impact on the output and quality of livestock products, including meat and milk. Above all, due to the significant size of the livestock industry, the demand for eubiotics is surging across the country. Thus, these factors are widening the scope of the eubiotics market across the US.

Furthermore, chicken meat is a widely consumed product in Canada. As per estimates, chicken production reached a high in 2019, with around 1.3 million metric tons of chicken produced. This indicates that animal agriculture plays a key role in supporting the country’s food production. Additionally, several processors are concentrating on protecting their farms from risks of various infectious diseases. Here, concerns pertaining to food safety, zoonotic diseases, and animal health are enhancing the demand for eubiotics, ultimately driving the eubiotics market’s growth across Canada.

Competitive Outlook

Koninklijke DSM NV, Kemin Industries Inc, Lallemand Inc, Beneo GmbH, Novus International Inc, Anpario Plc, and Archer Daniels Midland are major companies profiled in the eubiotics market.

1. North America Eubiotics Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on Eubiotics Market
2.2. Key Insights
2.2.1. Eubiotics as An Alternative to Antibiotics
2.2.2. Applications of Eubiotics in Calves' Gut Health
2.2.3. Developing Food Additive Platform Based on Grains
2.3. Porter’S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Mergers & Acquisitions
2.6.2. Contracts & Agreements
2.6.3. Product Launches
2.6.4. Expansions
2.7. Market Drivers
2.7.1. Rising Meat Consumption
2.7.2. Growing Awareness and Concerns Regarding Animal Health
2.7.3. Increasing Demand for Manufactured Feeds
2.8. Market Challenges
2.8.1. Unawareness About Eubiotics
2.9. Market Opportunities
2.9.1. Government Support for Eubiotics Use
2.9.2. Probiotics Spray Coatings
2.9.3. Essential Oils for Necrotic Enteritis

3. North America Eubiotics Market Outlook - by Type

3.1. Probiotics
3.2. Organic Acid
3.3. Prebiotics
3.4. Essential Oils

4. North America Eubiotics Market Outlook - by Form

4.1. Dry
4.2. Liquid

5. North America Eubiotics Market Outlook - by Livestock

5.1. Swine
5.2. Poultry
5.3. Ruminants
5.4. Aquaculture
5.5. Other Livestock

6. North America Eubiotics Market Outlook - by Application

6.1. Gut Health
6.2. Immunity
6.3. Yield Management
6.4. Other Applications

7. North America Eubiotics Industry Outlook - by End-User

7.1. Animals
7.2. Humans

8. North America Eubiotics Market – Regional Outlook

8.1. United States
8.2. Canada

9. Competitive Landscape

9.1. Anpario plc
9.2. Archer Daniels Midland
9.3. Basf Se
9.4. Behn Meyer Group
9.5. Beneo GmbH
9.6. Cargill Inc
9.7. Chr Hansen Holding as
9.8. Dupont De Nemours Inc
9.9. Kemin Industries Inc
9.10. Koninklijke Dsm Nv
9.11. Lallemand Inc
9.12. Lesaffre
9.13. Neospark Drugs and Chemicals Private Limited
9.14. Novus International Inc
9.15. Yara International Asa

10. Research Methodology & Scope

10.1. Research Scope & Deliverables
10.2. Sources of Data
10.3. Research Methodology

List of Tables

Table 1: North America Eubiotics Market, by Country, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Countries With the Highest Annual Meat Consumption
Table 4: Major Livestock Diseases in the World
Table 5: North America Eubiotics Market, by Type, 2021-2028 (In $ Million)
Table 6: North America Eubiotics Market, by Form, 2021-2028 (In $ Million)
Table 7: North America Eubiotics Market, by Livestock, 2021-2028 (In $ Million)
Table 8: North America Eubiotics Market, by Application, 2021-2028 (In $ Million)
Table 9: North America Eubiotics Market, by End-User, 2021-2028 (In $ Million)
Table 10: North America Eubiotics Market, by Country, 2021-2028 (In $ Million)

List of Figures

Figure 1: Market Attractiveness Index
Figure 2: North America Eubiotics Market, by Type, 2020 & 2028 (In %)
Figure 3: North America Eubiotics Market, by Probiotics, 2021-2028 (In $ Million)
Figure 4: North America Eubiotics Market, by Organic Acid, 2021-2028 (In $ Million)
Figure 5: North America Eubiotics Market, by Prebiotics, 2021-2028 (In $ Million)
Figure 6: North America Eubiotics Market, by Essential Oils, 2021-2028 (In $ Million)
Figure 7: North America Eubiotics Market, by Form, 2020 & 2028 (In %)
Figure 8: North America Eubiotics Market, by Dry, 2021-2028 (In $ Million)
Figure 9: North America Eubiotics Market, by Liquid, 2021-2028 (In $ Million)
Figure 10: North America Eubiotics Market, by Livestock, 2020 & 2028 (In %)
Figure 11: North America Eubiotics Market, by Swine, 2021-2028 (In $ Million)
Figure 12: North America Eubiotics Market, by Poultry, 2021-2028 (In $ Million)
Figure 13: North America Eubiotics Market, by Ruminants, 2021-2028 (In $ Million)
Figure 14: North America Eubiotics Market, by Aquaculture, 2021-2028 (In $ Million)
Figure 15: North America Eubiotics Market, by Other Livestock, 2021-2028 (In $ Million)
Figure 16: North America Eubiotics Market, by Application, 2020 & 2028 (In %)
Figure 17: North America Eubiotics Market, by Gut Health, 2021-2028 (In $ Million)
Figure 18: North America Eubiotics Market, by Immunity, 2021-2028 (In $ Million)
Figure 19: North America Eubiotics Market, by Yield Management, 2021-2028 (In $ Million)
Figure 20: North America Eubiotics Market, by Other Applications, 2021-2028 (In $ Million)
Figure 21: North America Eubiotics Market, by End-User, 2020 & 2028 (In %)
Figure 22: North America Eubiotics Market, by Animals, 2021-2028 (In $ Million)
Figure 23: North America Eubiotics Market, by Humans, 2021-2028 (In $ Million)
Figure 24: North America Eubiotics Market, Regional Outlook, 2020 & 2028 (In %)
Figure 25: United States Eubiotics Market 2021-2028 (In $ Million)
Figure 26: Canada Eubiotics Market 2021-2028 (In $ Million)